Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell immunotherapy.

Mark D McKee1, Allesandro Fichera, Michael I Nishimura

  • 1The University of Chicago, MC 7118, Chicago, IL 60637, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|November 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting PIM2 improves antitumor immunity through promoting effector function and persistence of CD8 T cells.

The Journal of clinical investigation·2026
Same author

H<sub>2</sub>S-Prdx4 axis mitigates Golgi stress to bolster tumor-reactive T cell immunotherapeutic response.

Science advances·2024
Same author

Quantification of circulating TCR-engineered T cells targeting a human endogenous retrovirus post-adoptive transfer using nanoplate digital PCR.

Molecular therapy. Methods & clinical development·2024
Same author

Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus.

Journal for immunotherapy of cancer·2024
Same author

CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary Angioedema.

The New England journal of medicine·2024
Same author

Nonactivated and IL-7 cultured CD19-specific CAR T cells are enriched in stem cell phenotypes and functionally superior.

Blood advances·2023
Same journal

The CD44 protein family: roles in embryogenesis and tumor progression.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Four varieties of voltage-gated proton channels.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Lurie's tubercle-count method to test TB vaccine efficacy in rabbits.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Optical spectroscopy of breast biopsies and human breast cancer xenografts in nude mice.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

The colostrum-deprived, artificially-reared, neonatal pig as a model animal for studying rotavirus gastroenteritis.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Action of polypeptide growth factors in colon cancer; development of new therapeutic approaches.

Frontiers in bioscience : a journal and virtual library·2017
See all related articles

Adoptive T cell immunotherapy involves re-infusing a patient's own tumor-specific T cells to fight cancer. Advances in T cell therapy, including genetic modification, show promise for broader clinical application.

Area of Science:

  • Immunology
  • Oncology
  • Gene Therapy

Background:

  • Adoptive T cell immunotherapy is a cancer treatment that utilizes a patient's own T cells.
  • This therapy has shown high effectiveness in a subset of patients with specific tumor types.
  • Current limitations are being addressed through ongoing research and development.

Purpose of the Study:

  • To review the current state and future directions of adoptive T cell immunotherapy for cancer treatment.
  • To highlight recent advancements and ongoing investigations in the field.
  • To discuss the potential for wider clinical adoption.

Main Methods:

  • Isolation of tumor-specific T cells from patient samples (tumor lesions, lymph nodes, peripheral blood).
  • In vitro activation and expansion of isolated T cells.

Related Experiment Videos

  • Application of novel approaches like non-myeloablative chemotherapy and genetic modification of T cells.

    • Main Results:

    • Adoptive T cell therapy has demonstrated significant efficacy in specific patient populations.
    • Recent advances include combining therapy with chemotherapy and genetically engineering T cells.
    • Clinical trials for gene-modified T cells are anticipated, focusing on improved activation, lifespan, and tumor targeting.

    Conclusions:

    • Adoptive immunotherapy is a dynamic field with ongoing research in T cell biology and gene therapy.
    • Future developments may enhance T cell activation, longevity, and tumor specificity.
    • Widespread adoption of adoptive therapy for cancer hinges on establishing clear clinical benefits for larger patient groups.